The CASP12 Antibody is primarily produced as a polyclonal antibody, generated by immunizing rabbits with synthetic peptides derived from mouse Caspase 12 (catalog #bs-1105R) . Its specificity targets regions spanning amino acids 201–300/420, ensuring broad recognition of Caspase 12 isoforms. The antibody is purified via Protein A chromatography and formulated in a TBS buffer with stabilizers for long-term storage . Key specifications include reactivity with mouse and rat tissues, suitability for Western blot (WB), ELISA, immunohistochemistry (IHC), and flow cytometry (FCM) .
| Parameter | Details |
|---|---|
| Host | Rabbit |
| Immunogen | KLH-conjugated synthetic peptide |
| Reactivity | Mouse, Rat |
| Applications | WB, ELISA, FCM, IHC-P, IHC-F, IF |
| Concentration | 1 µg/µL |
| Storage | TBS buffer with 50% glycerol |
The CASP12 Antibody has emerged as a critical tool in studying Caspase 12’s roles in inflammation, apoptosis, and cancer progression. Key applications include:
a. Cancer Prognostics
In cervical cancer (CC), elevated CASP12 expression correlates with improved 3-year survival rates (88.2% vs. 63.2% in low-expression groups) and serves as a diagnostic biomarker with an area under the ROC curve (AUC) of 0.865 . The antibody enables quantitative detection via qRT-PCR, revealing significant downregulation in CC tissues compared to controls (P < 0.05) .
b. Apoptosis Mechanisms
In renal tubular cells, the antibody has demonstrated Caspase 12’s activation during cisplatin-induced apoptosis, where it cleaves procaspase 12 prior to caspases 3 and 9 . This pathway involves oxidative stress from ER cytochrome P450 interactions, a mechanism validated by antibody-mediated inhibition of apoptosis in transfected cells .
c. Inflammation and Invasion
In nasopharyngeal carcinoma (NPC), the antibody identified Caspase 12’s role in NF-κB activation via IκBα degradation, enhancing matrix metalloproteinase-9 (MMP-9) expression and tumor invasion . siRNA knockdown or Casp12 inhibitors reduced invasion by ~23–25%, confirming its functional relevance .
a. Sepsis Susceptibility
The CASP12 gene exhibits a polymorphism generating either a functional (Csp12L) or inactive (Csp12S) protein. Populations of African descent predominantly carry the functional variant, associated with heightened bacterial responses (e.g., to LPS) and increased sepsis risk . The antibody facilitates population-wide screening for this polymorphism, aiding personalized medicine approaches .
b. Evolutionary Insights
The truncated Csp12S allele became fixed in non-African populations ~60–100 thousand years ago, likely conferring sepsis resistance in high-density populations . The antibody’s ability to distinguish isoforms supports studies linking this adaptation to ancient disease pressures .
Applications : Western blot assays
Sample type: Human cells
Review: Cleavage of caspase 12 was detected by Western blot. Combined treatment with tBHP and HDACi induced apoptosis in HCC cells. Apoptosis of HCC cells after treatment with tBHP (25 μmol/L), SAHA (1 mol/L), MS275 (1 μmol/L), or combinatorial treatment with tBHP and HDACi.